Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial

Tadakazu Hisamatsu, Reiko Kunisaki, Shiro Nakamura, Tomoyuki Tsujikawa, Fumihito Hirai, Hiroshi Nakase, Kenji Watanabe, Kaoru Yokoyama, Masakazu Nagahori, Takanori Kanai, Makoto Naganuma, Hirofumi Michimae, Akira Andoh, Akihiro Yamada, Tadashi Yokoyama, Noriko Kamata, Shinji Tanaka, Yasuo Suzuki, Toshifumi Hibi, Mamoru Watanabe

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)494-498
Number of pages5
JournalIntestinal Research
Volume16
Issue number3
DOIs
Publication statusPublished - 2018

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hisamatsu, T., Kunisaki, R., Nakamura, S., Tsujikawa, T., Hirai, F., Nakase, H., Watanabe, K., Yokoyama, K., Nagahori, M., Kanai, T., Naganuma, M., Michimae, H., Andoh, A., Yamada, A., Yokoyama, T., Kamata, N., Tanaka, S., Suzuki, Y., Hibi, T., & Watanabe, M. (2018). Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial. Intestinal Research, 16(3), 494-498. https://doi.org/10.5217/ir.2018.16.3.494